Solventum Free Cash Flow Per Share 2023-2025 | SOLV
Current and historical free cash flow per share for Solventum (SOLV) from 2023 to 2025. Free cash flow per share can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis Solventum free cash flow per share for the three months ending March 31, 2025 was $-0.46.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.562B | $8.254B |
| Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.314B | 25.57 |
| Elevance Health (ELV) | United States | $85.975B | 11.09 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.343B | 19.60 |
| DiDi Global (DIDIY) | China | $22.968B | 34.86 |
| Natera (NTRA) | United States | $21.581B | 0.00 |
| BioMerieux (BMXMF) | France | $15.705B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.357B | 0.00 |
| CochLear (CHEOY) | Australia | $11.324B | 0.00 |
| Revvity (RVTY) | United States | $10.833B | 18.64 |
| ICON (ICLR) | Ireland | $10.585B | 9.84 |
| Viatris (VTRS) | United States | $10.364B | 3.56 |
| Doximity (DOCS) | United States | $9.697B | 45.17 |
| Avantor (AVTR) | United States | $8.886B | 12.91 |
| HealthEquity (HQY) | United States | $8.734B | 42.97 |
| Medpace Holdings (MEDP) | United States | $8.538B | 22.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.763B | 13.25 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.142B | 24.42 |
| BrightSpring Health Services (BTSG) | United States | $4.077B | 37.74 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Concentras Parent (CON) | United States | $2.767B | 15.99 |
| Organon (OGN) | United States | $2.480B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.103B | 8.96 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.90 |
| Premier (PINC) | United States | $1.891B | 14.36 |
| Progyny (PGNY) | United States | $1.829B | 40.26 |
| PACS (PACS) | United States | $1.513B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.361B | 27.21 |
| Teladoc Health (TDOC) | United States | $1.225B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.30 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.003B | 0.00 | |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| CareDx (CDNA) | United States | $0.922B | 14.40 |
| Nutex Health (NUTX) | United States | $0.921B | 13.91 |
| AMN Healthcare Services Inc (AMN) | United States | $0.807B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.523B | 43.04 |
| LifeMD (LFMD) | United States | $0.522B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.387B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| KindlyMD (NAKA) | United States | $0.135B | 0.00 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.093B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.069B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |